Literature DB >> 12522049

Decreased epithelial cytokine responses in the duodenal mucosa of Helicobacter pylori-infected duodenal ulcer patients.

E Strömberg1, A Edebo, A-M Svennerholm, C Lindholm.   

Abstract

Helicobacter pylori colonizes the human stomach and areas of gastric metaplasia in the duodenum, but only a minority of those that are infected develop symptoms, e.g., peptic ulcers. Although most ulcers occur in the duodenum, almost all studies of mucosal immune responses against the infection have been limited to responses in the stomach. In the present study we evaluated whether there are differences in the levels of proinflammatory cytokines as well as immunoregulatory cytokines in the duodenal mucosa of duodenal ulcer (DU) patients and asymptomatic (AS) carriers which may be related to the development of duodenal ulcers. Duodenal biopsy specimens collected from normal mucosa as well as metaplastic mucosa of DU patients, AS carriers, and uninfected controls were analyzed for a number of cytokines by immunohistochemistry. Interestingly, the level of epithelial staining for several cytokines, e.g., interleukin-8 (IL-8), transforming growth factor beta (TGF-beta), and gamma interferon (IFN-gamma), was found to be significantly lower in DU patients than in AS carriers and uninfected individuals. No differences were observed when cytokine staining in normal and metaplastic biopsy specimens was compared. However, larger numbers of IL-8-, IL-6-, TGF-beta-, and IFN-gamma-positive mononuclear cells were observed in the duodenal lamina propria of both DU patients and AS carriers than in that of the uninfected controls. Our finding that a number of cytokines that may be important for the mucosal host defense against H. pylori are strongly decreased in the duodenal epithelium of ulcer patients suggests that a down-regulated immune response plays a role in the development of duodenal ulcers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12522049      PMCID: PMC145289          DOI: 10.1128/cdli.10.1.116-124.2003

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  56 in total

1.  TNF and LTA gene polymorphisms reveal different risk in gastric and duodenal ulcer patients.

Authors:  A Lanas; M A García-González; S Santolaria; J B Crusius; M T Serrano; R Benito; A S Peña
Journal:  Genes Immun       Date:  2001-12       Impact factor: 2.676

2.  Differences in surface-exposed antigen expression between Helicobacter pylori strains isolated from duodenal ulcer patients and from asymptomatic subjects.

Authors:  A C Thoreson; A Hamlet; J Celik; M Byström; S Nyström; L Olbe; A M Svennerholm
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

3.  Relation between clinical presentation, Helicobacter pylori density, interleukin 1beta and 8 production, and cagA status.

Authors:  Y Yamaoka; T Kodama; M Kita; J Imanishi; K Kashima; D Y Graham
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

4.  The polymorphic IL-1B and IL-1RN genes in the aetiopathogenesis of peptic ulcer.

Authors:  M A Garcia-Gonzalez; A Lanas; S Santolaria; J B Crusius; M T Serrano; A S Peña
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

5.  Interleukin-8 receptor knockout mice have subepithelial neutrophil entrapment and renal scarring following acute pyelonephritis.

Authors:  L Hang; B Frendéus; G Godaly; C Svanborg
Journal:  J Infect Dis       Date:  2000-11-08       Impact factor: 5.226

6.  Induction of chemokine and cytokine responses by Helicobacter pylori in human stomach explants.

Authors:  C Lindholm; M Quiding-Järbrink; H Lönroth; A M Svennerholm
Journal:  Scand J Gastroenterol       Date:  2001-10       Impact factor: 2.423

7.  Gastric metaplasia in the duodenal bulb shows increased mucosal interleukin-8 activity in Helicobacter pylori-positive duodenal ulcer patients.

Authors:  M Noshiro; K Kusugami; T Sakai; A Imada; T Ando; K Ina; K Nobata; K Morise; H Kaneko; M Ito; Y Nishio
Journal:  Scand J Gastroenterol       Date:  2000-05       Impact factor: 2.423

8.  Local cytokine response in Helicobacter pylori-infected subjects.

Authors:  C Lindholm; M Quiding-Järbrink; H Lönroth; A Hamlet; A M Svennerholm
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

9.  Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation.

Authors:  S Read; V Malmström; F Powrie
Journal:  J Exp Med       Date:  2000-07-17       Impact factor: 14.307

10.  Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta.

Authors:  K Nakamura; A Kitani; W Strober
Journal:  J Exp Med       Date:  2001-09-03       Impact factor: 14.307

View more
  6 in total

1.  Mucosal FOXP3-expressing CD4+ CD25high regulatory T cells in Helicobacter pylori-infected patients.

Authors:  Anna Lundgren; Erika Strömberg; Asa Sjöling; Catharina Lindholm; Karin Enarsson; Anders Edebo; Erik Johnsson; Elisabeth Suri-Payer; Pia Larsson; Anna Rudin; Ann-Mari Svennerholm; B Samuel Lundin
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

2.  Suppressed Gastric Mucosal TGF-beta1 Increases Susceptibility to H. pylori-Induced Gastric Inflammation and Ulceration: A Stupid Host Defense Response.

Authors:  Yunjeong Jo; Sang Uk Han; Yoon Jae Kim; Ju Hyeon Kim; Shin Tae Kim; Seong-Jin Kim; Ki-Baik Hahm
Journal:  Gut Liver       Date:  2010-03-25       Impact factor: 4.519

3.  Down-regulation of epithelial IL-8 responses in Helicobacter pylori-infected duodenal ulcer patients depends on host factors, rather than bacterial factors.

Authors:  E Strömberg; A Edebo; B S Lundin; P Bergin; M Brisslert; A M Svennerholm; C Lindholm
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

4.  Detection of Helicobacter pylori in oropharyngeal lymphatic tissue with real-time PCR and assessment of its carcinogenic potential.

Authors:  Petr Lukeš; Emil Pavlík; Bela Potuznikova; Eva Nartova; Eva Foltynova; Jan Plzak; Rami Katra; Ivan Sterzl; Jirina Bartunkova; Jan Betka; Jaromir Astl
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-06-07       Impact factor: 2.503

Review 5.  Exploring alternative treatments for Helicobacter pylori infection.

Authors:  Guadalupe Ayala; Wendy Itzel Escobedo-Hinojosa; Carlos Felipe de la Cruz-Herrera; Irma Romero
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

6.  Contribution of secretory antibodies to intestinal mucosal immunity against Helicobacter pylori.

Authors:  Rebecca J Gorrell; Odilia L C Wijburg; John S Pedersen; Anna K Walduck; Terry Kwok; Richard A Strugnell; Roy M Robins-Browne
Journal:  Infect Immun       Date:  2013-08-05       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.